La maladie de Parkinson en France (serveur d'exploration) - Checkpoint (PubMed)

Index « Auteurs » - entrée « Erwan Bezard »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Ernesto Palmero-Soler < Erwan Bezard < Erwan Bézard  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 61.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000054 (2016) Sandra Dovero [France] ; Christian Gross [France] ; Erwan Bezard [France]Unexpected toxicity of very low dose MPTP in mice: A clue to the etiology of Parkinson's disease?
000068 (2016) Benjamin Dehay [France] ; Mickael Decressac [Italie] ; Mathieu Bourdenx [France] ; Irene Guadagnino [Italie] ; Pierre-Olivier Fernagut [France] ; Anna Tamburrino [Italie] ; Fares Bassil [France] ; Wassilios G. Meissner [France] ; Erwan Bezard [France]Targeting α-synuclein: Therapeutic options.
000081 (2016) Michel Engeln [France] ; Matthieu F. Bastide [France] ; Estelle Toulmé [France] ; Benjamin Dehay [France] ; Mathieu Bourdenx [France] ; Evelyne Doudnikoff [France] ; Qin Li [République populaire de Chine] ; Christian E. Gross [France] ; Eric Boué-Grabot [France] ; Antonio Pisani [Italie] ; Erwan Bezard [France] ; Pierre-Olivier Fernagut [France]Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA-Induced Dyskinesia.
000104 (2016) Thibaud Thiollier [France] ; Caisheng Wu ; Hugues Contamin [France] ; Qin Li [Royaume-Uni] ; Jinlan Zhang ; Erwan Bezard [France]Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease.
000121 (2016) Mathieu Bourdenx [France] ; Jonathan Daniel [France] ; Emilie Genin [France] ; Federico N. Soria [France] ; Mireille Blanchard-Desce [France] ; Erwan Bezard [France] ; Benjamin Dehay [France]Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases.
000124 (2016) Michel Engeln [France] ; Solène Ansquer [France] ; Emilie Dugast [France] ; Erwan Bezard [France] ; David Belin [Royaume-Uni] ; Pierre-Olivier Fernagut [France]Multi-facetted impulsivity following nigral degeneration and dopamine replacement therapy.
000154 (2016) Mathieu Schmitt [Belgique] ; Benjamin Dehay [France] ; Erwan Bezard [France] ; F Javier Garcia-Ladona [Belgique]Harnessing the trophic and modulatory potential of statins in a dopaminergic cell line.
000156 (2016) Ludovico Arcuri [Italie] ; Riccardo Viaro [Italie] ; Simone Bido [Italie] ; Francesco Longo [Italie] ; Mariangela Calcagno [Italie] ; Pierre-Olivier Fernagut [France] ; Nurulain T. Zaveri [États-Unis] ; Girolamo Cal [Italie] ; Erwan Bezard [France] ; Michele Morari [Italie]Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease.
000207 (2016) Annalisa Pinna [Italie] ; Wai Kin D. Ko [Royaume-Uni] ; Giulia Costa [Italie] ; Elisabetta Tronci [Italie] ; Camino Fidalgo [Italie] ; Nicola Simola [Italie] ; Qin Li [Royaume-Uni] ; Mojgan Aghazadeh Tabrizi [Italie] ; Erwan Bezard [Royaume-Uni] ; Manolo Carta [Italie] ; Micaela Morelli [Italie]Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease.
000210 (2016) Wai Kin D. Ko [Royaume-Uni] ; Sandrine M. Camus [Royaume-Uni] ; Qin Li [Royaume-Uni] ; Jianzhong Yang [Royaume-Uni] ; Steve Mcguire [Royaume-Uni] ; Elsa Y. Pioli [Royaume-Uni] ; Erwan Bezard [France]An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models.
000211 (2016) Anna Migdalska-Richards [Royaume-Uni] ; Liam Daly [Royaume-Uni] ; Erwan Bezard [France] ; Anthony H V. Schapira [Royaume-Uni]Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.
000213 (2016) Benjamin Dehay [France] ; Miquel Vila [Espagne] ; Erwan Bezard [France] ; Patrik Brundin [États-Unis] ; Jeffrey H. Kordower [États-Unis]Alpha-synuclein propagation: New insights from animal models.
000225 (2016) François Tison [France] ; Charlotte Keywood [Suisse] ; Mark Wakefield [Suisse] ; Franck Durif [France] ; Jean-Christophe Corvol [France] ; Karla Eggert [Allemagne] ; Mark Lew [États-Unis] ; Stuart Isaacson [États-Unis] ; Erwan Bezard [France] ; Sonia-Maria Poli [Suisse] ; Christopher G. Goetz [États-Unis] ; Claudia Trenkwalder [Allemagne] ; Olivier Rascol [France]A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease.
000242 (2015) Michel Engeln [France] ; Philippe De Deurwaerdère [France] ; Qin Li [République populaire de Chine] ; Erwan Bezard [République populaire de Chine] ; Pierre-Olivier Fernagut [France]Widespread Monoaminergic Dysregulation of Both Motor and Non-Motor Circuits in Parkinsonism and Dyskinesia.
000244 (2015) Sandrine Camus [Royaume-Uni] ; Wai Kin D. Ko [Royaume-Uni] ; Elsa Pioli [Royaume-Uni] ; Erwan Bezard [France]Why bother using non-human primate models of cognitive disorders in translational research?
000261 (2015) Nikhil M. Urs [États-Unis] ; Simone Bido [France] ; Sean M. Peterson ; Tanya L. Daigle ; Caroline E. Bass [États-Unis] ; Raul R. Gainetdinov [Russie] ; Erwan Bezard [France] ; Marc G. Caron [États-Unis]Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.
000262 (2015) Benjamin Dehay [France] ; Mathieu Bourdenx [France] ; Philippe Gorry [France] ; Serge Przedborski [États-Unis] ; Miquel Vila [Espagne] ; Stéphane Hunot [France] ; Andrew Singleton [États-Unis] ; C Warren Olanow [États-Unis] ; Kalpana M. Merchant [États-Unis] ; Erwan Bezard [France] ; Gregory A. Petsko [États-Unis] ; Wassilios G. Meissner [France]Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations.
000286 (2015) Mathieu Bourdenx [France] ; Nikolaos Stavros Koulakiotis [Grèce] ; Despina Sanoudou [Grèce] ; Erwan Bezard [France] ; Benjamin Dehay [France] ; Anthony Tsarbopoulos [Grèce]Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies.
000391 (2015) Erwan Bezard [France] ; Manolo Carta [Italie]Could the serotonin theory give rise to a treatment for levodopa-induced dyskinesia in Parkinson's disease?
000446 (2014) Anthony H V. Schapira [Royaume-Uni] ; C Warren Olanow [États-Unis] ; J Timothy Greenamyre [États-Unis] ; Erwan Bezard [France]Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.
000456 (2014) Wai Kin D. Ko [France] ; Marie-Laure Martin-Negrier [France] ; Erwan Bezard [France] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni]RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Erwan Bezard" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "Erwan Bezard" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Erwan Bezard
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024